| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neogenomics Inc (NEO) has 14 insiders with recent SEC Form 4 filings, including 7 buys and 5 sells. NEO is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 176.4K | $1.58M | - | |
| COO | 143.8K | $1.29M | - | |
| Dir | 131.0K | $1.17M | - | |
| VP | 75.3K | $674.9K | - | |
| Dir | 44.0K | $394.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 9, 2016 | Van Oort Douglas M | Chairman And CEO | Sale+OE | 450,000 | $7.10 | $3,193,900.00 | -11.4% | |
| Mar 4, 2016 | Johnson Kevin C | Director | Buy | 22,007 | $6.78 | $149,195.88 | +10.7% | |
| Mar 3, 2016 | Hannah Alison L. | Director | Buy | 10,000 | $6.90 | $69,000.00 | +641.0% | |
| Dec 21, 2015 | Tetrault Lynn A. | Director | Buy | 9,500 | $8.21 | $77,995.00 | +187.7% | |
| Dec 7, 2015 | Tetrault Lynn A. | Director | Buy | 3,500 | $7.72 | $27,020.00 | +224.4% | |
| Dec 3, 2015 | Shovlin Robert J. | Chief Operating Officer | Buy | 6,550 | $7.75 | $50,762.50 | New | |
| Nov 27, 2015 | Jones Steven C | Executive VP Of Finance | Sell | 385,000 | $8.09 | $3,115,315.00 | -5.4% | |
| Nov 2, 2015 | Crowther Bruce K | Director | Buy | 6,400 | $7.81 | $49,977.60 | +178.8% |